|
Raza, Azra; Qawi, Huma; Mehdi, Murtaza et al. (2004) Translational research in myelodysplastic syndromes. Rev Clin Exp Hematol 8:E2
|
|
Preisler, H D; Raza, A; Larson, R et al. (1994) The relationship of the in vivo cell cycle characteristics and treatment outcome in acute myelogenous leukemia to the expression of the FMS and MYC proto-oncogenes. Leuk Lymphoma 14:273-8
|
|
Preisler, H D; Raza, A; Gopal, V et al. (1994) The study of acute leukemia cells by means of acridine orange staining and flow cytometry. Leuk Lymphoma 13:61-73
|
|
Preisler, H D; Banavali, S D; Yin, M et al. (1994) Parallel studies of clonogenic leukaemia cells and the leukaemia cell population as a whole in acute myelogenous leukaemia. Eur J Cancer 30A:1511-6
|
|
Yin, M; Silvestri, F F; Banavali, S D et al. (1993) Clonogenic potential of myeloid leukaemia cells in vitro is restricted to leukaemia cells expressing the CD34 antigen. Eur J Cancer 29A:2279-83
|
|
Goldberg, J; Gryn, J; Raza, A et al. (1993) Mitoxantrone and 5-azacytidine for refractory/relapsed ANLL or CML in blast crisis: a leukemia intergroup study. Am J Hematol 43:286-90
|
|
Preisler, H; Raza, A (1993) An overview of some studies of chronic myelogenous leukemia: biological-clinical observations and viewing the disease as a chaotic system. Leuk Lymphoma 11 Suppl 1:145-50
|
|
Raza, A; Preisler, H D; Li, Y Q et al. (1993) Biological characteristics of newly diagnosed poor prognosis acute myelogenous leukemia. Am J Hematol 42:359-66
|
|
Raza, A; Preisler, H; Lampkin, B et al. (1993) Clinical and prognostic significance of in vivo differentiation in acute myeloid leukemia. Am J Hematol 42:147-57
|
|
Preisler, H (1993) Poor prognosis acute myelogenous leukemia. Leuk Lymphoma 9:273-83
|
Showing the most recent 10 out of 101 publications
